Literature DB >> 3410567

Influence of dialysate and membrane biocompatibility on hemodynamic stability in hemodialysis.

C Quereda1, L Orofino, R Marcen, J Sabater, R Matesanz, J Ortuño.   

Abstract

The contributions of membrane biocompatibility, dialysate temperature and sodium concentration to hemodynamic stability during hemodialysis were studied in 8 patients with a high incidence of hemodialysis-induced symptomatic hypotension. Patients were treated during 8 different periods, randomly ordered in each case, resulting from the combination of the following: the membrane, either Cuprophan or Polyacrylonitrile; the dialysate temperature, 37 or 35 degrees C, and the sodium concentration, 133 or 139 mmol/l. The incidence of symptomatic hypotension was lower at 35 degrees C in the entire study with either membrane and either sodium concentration. It was also lower with a sodium concentration of 139 mmol/l with either temperature and either membrane. There was a lower incidence of symptomatic hypotension when using Polyacrylonitrile, but this difference was not significant. We conclude that changes in physicochemical parameters of dialysate lead to worth-while improvement of symptomatic hypotension in hemodialysis patients, but membrane biocompatibility seems to play a minor role.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3410567

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  4 in total

Review 1.  Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

Authors:  A M Macleod; M Campbell; J D Cody; C Daly; C Donaldson; A Grant; I Khan; K S Rabindranath; L Vale; S Wallace
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

2.  Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis.

Authors:  Yasushi Tsujimoto; Hiraku Tsujimoto; Yukihiko Nakata; Yuki Kataoka; Miho Kimachi; Sayaka Shimizu; Tatsuyoshi Ikenoue; Shingo Fukuma; Yosuke Yamamoto; Shunichi Fukuhara
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05

Review 3.  Management of acute intradialytic cardiovascular complications: Updated overview (Review).

Authors:  Delia Timofte; Maria-Daniela Tanasescu; Daniela Gabriela Balan; Adrian Tulin; Ovidiu Stiru; Ileana Adela Vacaroiu; Andrada Mihai; Cristian Constantin Popa; Cristina-Ileana Cosconel; Mihaly Enyedi; Daniela Miricescu; Raluca Ioana Papacocea; Dorin Ionescu
Journal:  Exp Ther Med       Date:  2021-01-26       Impact factor: 2.447

4.  Low dialysate sodium levels for chronic haemodialysis.

Authors:  Joanna L Dunlop; Alain C Vandal; Mark R Marshall
Journal:  Cochrane Database Syst Rev       Date:  2019-01-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.